CN109575060B - Synthesis of spiro bisboron catalyst and application of spiro bisboron catalyst in hydrogenation reaction - Google Patents

Synthesis of spiro bisboron catalyst and application of spiro bisboron catalyst in hydrogenation reaction Download PDF

Info

Publication number
CN109575060B
CN109575060B CN201811561367.5A CN201811561367A CN109575060B CN 109575060 B CN109575060 B CN 109575060B CN 201811561367 A CN201811561367 A CN 201811561367A CN 109575060 B CN109575060 B CN 109575060B
Authority
CN
China
Prior art keywords
spiro
chiral
compound
catalyst
aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201811561367.5A
Other languages
Chinese (zh)
Other versions
CN109575060A (en
Inventor
王晓晨
李祥
田俊杰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nankai University
Original Assignee
Nankai University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nankai University filed Critical Nankai University
Priority to CN201811561367.5A priority Critical patent/CN109575060B/en
Publication of CN109575060A publication Critical patent/CN109575060A/en
Application granted granted Critical
Publication of CN109575060B publication Critical patent/CN109575060B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02Boron compounds
    • C07F5/027Organoboranes and organoborohydrides
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/02Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides
    • B01J31/12Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides containing organo-metallic compounds or metal hydrides
    • B01J31/14Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides containing organo-metallic compounds or metal hydrides of aluminium or boron
    • B01J31/146Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides containing organo-metallic compounds or metal hydrides of aluminium or boron of boron
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/04Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms
    • C07D215/06Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms having only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to the ring nitrogen atom
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2231/00Catalytic reactions performed with catalysts classified in B01J31/00
    • B01J2231/60Reduction reactions, e.g. hydrogenation
    • B01J2231/64Reductions in general of organic substrates, e.g. hydride reductions or hydrogenations
    • B01J2231/641Hydrogenation of organic substrates, i.e. H2 or H-transfer hydrogenations, e.g. Fischer-Tropsch processes
    • B01J2231/646Hydrogenation of organic substrates, i.e. H2 or H-transfer hydrogenations, e.g. Fischer-Tropsch processes of aromatic or heteroaromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

The invention relates to a compound having C2Synthesizing a symmetrical chiral spiro diene compound, and preparing a series of chiral spiro bisboron catalysts by reacting the chiral spiro diene compound with a boron hydride compound. The spiro diboron catalysts show high activity and enantioselectivity in asymmetric hydrogenation of quinoline compounds, and belong to the technical field of application. The method mainly solves the problems that the prior quinoline asymmetric hydrogenation reaction method needs to use a noble metal catalyst, has poor functional group tolerance and the like, realizes the nonmetal-catalyzed quinoline asymmetric hydrogenation reaction, and has wide reaction substrate range and strong functional group tolerance. The invention can be applied to pharmaceutical research and chemical production.

Description

Synthesis of spiro bisboron catalyst and application of spiro bisboron catalyst in hydrogenation reaction
Technical Field
The invention relates to a novel compound having C2The synthesis of the symmetrical spiro diene compound and the in-situ preparation of the spiro diboron catalyst by hydroboration reaction show high activity and enantioselectivity in the asymmetric hydrogenation of quinoline, and belong to the technical field of organic chemical synthesis methodology research and application.
Background
In 2006, professor d.w.stephan of university of toronto found B (C)6F5)3And the highly hindered bases (tri-tert-butylphosphine) do not form the classical lewis acid-base adducts but exist as acid-base pairs that can activate hydrogen at room temperature and reduce some unsaturated compounds. Based on this, some chiral boron catalysts were synthesized and used in asymmetric hydrogenation of various substrates (as shown in the following figure). However, the field is still in the beginning, the chiral boron catalyst reported at present is very limited, and the asymmetric hydrogenation reaction of a plurality of heterocyclic compounds is not solved, so that the development of a novel and efficient chiral catalyst is an important content of research in the field.
Figure GDA0002692754980000011
Disclosure of Invention
The content of the invention comprises: 1. preparing a novel chiral spirocyclic diene compound; 2. preparing a spiro diboron catalyst through a hydroboration reaction of a spiro diene compound and identifying the structure of the spiro diboron catalyst; 3. the application of the spiro bisboron catalyst in asymmetric hydrogenation of quinoline.
1. The chiral spirodiene compound of the present invention has the following structural formula (the absolute configuration of the spirocyclic skeleton is (R) or (S)):
Figure GDA0002692754980000021
the chiral spiro diene is characterized in that the molecule has a spiro [4.4] -nonane skeleton, and R groups in the structural formula are aryl or alkyl. The synthesis method comprises the following steps:
Figure GDA0002692754980000022
the first step is as follows: racemic spiro [4.4] -1, 6-nonanedione (rac-1) (the preparation reference: Synth. Commun.1999,29,3829.) and (R) -phenethylamino oxalyl hydrazine are reacted under the catalysis of iodine under reflux overnight to obtain a pair of diastereoisomer dihydrazone compound intermediates, and the (R) -dihydrazone compound with single configuration can be separated by twice recrystallization in ethanol, and the intermediate dihydrazone compound is hydrolyzed in an iodine-potassium iodide system to obtain an optically pure product (R) -spiro [4.4] -1, 6-nonanedione ((R) -1). Wherein the molar ratio of racemic spiro [4.4] -1, 6-nonanedione (rac-1) to (R) -phenethylamino oxalyl hydrazine is 1:1, and the iodine simple substance is catalytic amount.
The second step is that: reacting (R) -spiro [4.4] -1, 6-nonanedione ((R) -1) and 2- [ N-N-bis (trifluoromethanesulfonyl) amino ] pyridine in tetrahydrofuran at-78 ℃ with potassium bis (trimethylsilyl) amide as a base for 40 minutes to give an enol trifluoromethanesulfonate compound 2. Wherein the molar ratio of (R) -spiro [4.4] -1, 6-nonanedione ((R) -1), 2- [ N-bis (trifluoromethanesulfonyl) amino ] pyridine and bis (trimethylsilyl) amino potassium is 1:3: 3.
The third step: toluene and ethanol are mixed according to the volume ratio of 3:1 to serve as a mixed solvent, under the condition of heating reflux, the triflate enol ester compound (2) and an aryl or alkyl boric acid reagent undergo Suzuki coupling reaction in the presence of tetrakis (triphenylphosphine) palladium and alkali, and the chiral spirocyclic diene compound (3) is obtained after 5 hours of reaction. Wherein the molar ratio of the triflate enol ester compound (2) to the boric acid reagent is 1:4, and the dosage of the tetrakis (triphenylphosphine) palladium is 10 mol%. The boric acid reagent has a molecular formula of RB (OH)2And R is aryl or alkyl.
2. Preparation and structure identification of the chiral spiro-diboron catalyst:
Figure GDA0002692754980000023
in a glove box, a chiral spirocyclic diene compound and HB (C)6F5)2And adding a solvent toluene into a reaction bottle, stirring for 15 minutes at a specified temperature, and then recovering to room temperature to prepare the chiral spiro diboron catalyst. And adding isoquinoline or pyridine (L) to react with the prepared chiral spiro diboron catalyst, stirring for 30 minutes at room temperature, removing the solvent, and recrystallizing, separating and purifying to obtain an adduct of the chiral spiro diboron catalyst and the L. Chiral spirocyclic diene compound, HB (C)6F5)2And L (isoquinoline or pyridine) in a molar ratio of 1:2: 4. The structure of the adduct is confirmed by X-ray single crystal diffraction, and the structure of the prepared chiral spiro-diboron catalyst is further determined. Wherein, HB (C)6F5)2Other fluorine-containing aryl boron hydrides may be substituted.
3. The chiral spiro diboron catalyst is used for catalyzing asymmetric hydrogenation of quinoline:
Figure GDA0002692754980000031
the chiral spiro diboron catalyst can be applied to asymmetric hydrogenation of quinoline compounds to obtain 2-substituted tetrahydroquinoline compounds with high conversion number and extremely high enantioselectivity.
The invention has the advantages that:
1. the boron catalyst replaces a transition metal catalyst, so that the cost is saved, and the problem of heavy metal residue in the drug synthesis is solved.
2. The spirocyclic diboron catalyst is low in dosage, can be amplified to gram level experiments, and is mild in reaction conditions.
3. The developed asymmetric hydrogenation reaction can obtain 2-substituted tetrahydroquinoline with high reaction activity and extremely high enantioselectivity, and has wide substrate range and strong functional group compatibility.
Detailed description of the invention
The following examples will better illustrate the invention, but it should be emphasized that the invention is in no way limited to what is shown in these examples. The following examples show different aspects of the invention. The data presented include specific operating and reaction conditions and products. The purity of the product was identified by nuclear magnetism.
Example 1: synthesis of chiral spirocyclic diene Compound 3a
Figure GDA0002692754980000041
The first step is as follows: resolution of spiro [4.4] -1, 6-nonanedione
(R) -phenethylamino oxalyl hydrazide (4.15g,2eq) was added to a 250mL dry round bottom flask followed by 1.52g racemic spiro [4.4] -1, 6-nonanedione and a small amount of iodine, 120mL anhydrous dichloromethane were added under argon, an aqueous trap and reflux condenser were installed and heated to reflux overnight. After the reaction, the system is cooled to room temperature, diatomite is filtered to remove insoluble solid, dichloromethane is removed by reduced pressure rotary evaporation to obtain a yellow solid crude product, and anhydrous ethanol is recrystallized and purified to obtain 3.5g of white powdery solid dihydrazone compound intermediate with the yield of 66%.
2.0g of the dihydrazone compound intermediate was added to a 500mL eggplant-shaped bottleAnd recrystallizing twice by using absolute ethyl alcohol to obtain 600mg of the single-configuration dihydrazone compound with the yield of 60 percent.1H NMR(400MHz,CDCl3)9.71(s,2H),8.25(d,J=8.3Hz,2H),7.39-7.22(m,8H),7.22-7.12(m,2H),5.17-4.98(m,2H),2.57-2.39(m,4H),2.36-2.26(m,2H),2.24-2.12(m,2H),1.91-1.71(m,4H),1.59(d,J=6.8Hz,6H);13C NMR(101MHz,CDCl3)172.8,158.7,155.1,142.1,128.7,127.6,126.2,57.8,49.6,37.4,28.0,21.6,21.5.
2.0g of the dihydrazone compound of a single configuration was charged into a 250mL round-bottomed flask, potassium iodide (800mg) and elemental iodine (200mg) were sequentially added, acetone (80mL) and water (20mL) were added as a mixed solvent, and the reaction solution was heated under reflux for 40 minutes and monitored by TLC. After the reaction is completed, dropwise adding saturated sodium thiosulfate solution while stirring to quench iodine, changing the reaction solution from brown yellow to colorless, carrying out reduced pressure rotary evaporation to remove acetone, extracting the residue with dichloromethane for three times, washing the combined organic phase with saturated sodium chloride solution, drying with anhydrous sodium sulfate, removing the solvent by rotary evaporation, and carrying out silica gel column chromatography on the crude product to obtain a white solid product (R) -spiro [ 4.4.4%]-1, 6-nonanedione ((R) -1) (385mg), 67% yield.1H NMR(400MHz,CDCl3)2.42-2.13(m,8H),1.93-1.77(m,4H);13C NMR(101MHz,CDCl3)217.0,64.5,38.6,34.4,19.9.
The second step is that: synthesis of Compound 2
Under the protection of argon, the (R) -spiro [4.4] is reacted]-1, 6-nonanedione ((R) -1) (400mg) and 2- [ N, N-bis (trifluoromethanesulfonyl) amino]Pyridine (2.4eq,2.3g) was added to a dry 100mL Schlenk reaction flask, purged 3 times, and added to 30mL of anhydrous tetrahydrofuran. The system is cooled to-78 ℃, bis (trimethylsilyl) amino potassium (3eq) is dropwise added into the reaction system under the protection of argon, the reaction is kept for 40 minutes after the dropwise addition, and the reaction is monitored by TLC. Quenching the reaction by using a saturated sodium bicarbonate solution after the reaction is finished, extracting the reaction solution for three times (3X 20mL) by using ethyl acetate, washing the combined organic phase by using a 5% sodium hydroxide solution and a saturated sodium chloride solution in turn, drying anhydrous potassium carbonate, filtering to remove a drying agent, carrying out reduced pressure rotary evaporation to remove the solvent, carrying out chromatographic separation on the crude product by using a silica gel column to obtain a yellow liquid product, namely, a triflate enol ester compound (2) (915mg),the yield was 83%.1H NMR(400MHz,CDCl3)5.80(t,J=2.5Hz,2H),2.52-2.38(m,4H),2.37-2.29(m,2H),2.04-1.97(m,2H);13C NMR(101MHz,CDCl3)148.5,123.4,120.2,117.4,117.0,113.8,58.3,33.3,26.2.
The third step: synthesis of chiral spirocyclic dienes
Under the protection of argon, the alkene ester trifluoromethanesulfonate compound (2) (500mg), phenylboronic acid (4eq, 585mg) and tetrakis (triphenylphosphine) palladium (10 mol%) were added into a 100mL three-necked flask, the gas was purged 3 times, the degassed toluene ethanol mixture (3:1,30mL) and sodium carbonate solution (15mL) were added, the system was frozen and degassed three times with liquid nitrogen, and the mixture was returned to room temperature and heated at 80 ℃ for reflux for 5 hours. TLC monitors the reaction progress, after complete conversion, the system is cooled to room temperature, saturated ammonium chloride solution is added, an organic phase is separated, an aqueous phase is extracted with ethyl acetate for three times, the organic phase is washed with saturated salt water twice, dried by anhydrous sodium sulfate, filtered to remove a drying agent, solvent is removed by rotary evaporation, and a crude product is subjected to normal hexane column chromatography to obtain 327mg of white powdery solid 3a with the yield of 55%.1H NMR(400MHz,CDCl3)7.51-7.49(m,4H),7.23-7.14(m,6H),6.20(t,J=2.6Hz,2H),2.51-2.42(m,4H),2.28-2.20(m,2H),2.08-2.02(m,2H);13C NMR(101MHz,CDCl3)148.1,136.6,128.4,128.1,126.7,64.4,37.5,30.2.
Example 2: synthesis and identification of spiro-bis-boron catalyst 4a
Figure GDA0002692754980000051
In a glove box, 3a (13.6mg,0.05mmol) and HB (C) were added to the reaction flask in this order6F5)2(34.6mg,0.1mmol) and toluene (1.0mL) were reacted at 25 ℃ for 15 minutes. Further, isoquinoline (25.8mg,0.2mmol) and toluene (0.5mL) were added, and the reaction was continued at 25 ℃ for 30 minutes. After the reaction is finished, toluene is removed by reduced pressure distillation to obtain white powdery solid, and internal standard CH is added2Br2By passing1The nuclear magnetic yield was 95% by H NMR. The crude product was recrystallized from dichloromethane and n-hexane to give 4 a.2L.1H NMR(400MHz,CD2Cl2)8.74(s,2H),8.04(d,J=6.8Hz,2H),7.83(t,J=7.5Hz,2H),7.74(d,J=8.1Hz,2H),7.62(t,J=7.4Hz,2H),7.59-7.30(m,8H),7.16(t,J=7.1Hz,2H),6.87(br,2H),6.69(br,2H),2.92(t,J=9.6Hz,2H),2.32-2.18(m,2H),2.14(d,J=9.0Hz,2H),1.80-1.54(m,4H),0.86(dd,J=19.2,11.5Hz,2H);13C NMR(101MHz,CD2Cl2)149.6,137.0,136.0,134.6,131.8,129.9,129.8,129.0,127.8,127.2,127.0,126.0,125.8,122.7,61.4,53.1,34.5,33.5,27.4.
Example 3: synthesis of (R) -2-methyl-1, 2,3, 4-tetrahydroquinoline (P1)
Figure GDA0002692754980000061
In a glove box filled with nitrogen, chiral spirodiene compound 3a (3.4mg,0.0125mmol,5 mol%) and HB (C)6F5)2(8.65mg,0.025mmol,10 mol%) was added to a 10mL cuvette, dissolved in 2mL of trifluorotoluene, and reacted at 25 ℃ for 15 minutes. The system was cooled to room temperature and then 2-methylquinoline S1(35.8mg,0.25mmol) and 3mL of trifluorotoluene were added, whereupon the tube was transferred to an autoclave and after three replacements of hydrogen gas, hydrogen was finally charged to 50bar and reacted at-20 ℃ for 24 h. After the reaction, hydrogen was released, the solvent was removed by rotary evaporation, and the residue was separated and purified by silica gel column chromatography to give a hydrogenated product P1 as a colorless oily liquid with a yield of 97% and an enantioselectivity of 90% ee.1H NMR(400MHz,CDCl3)7.00-6.95(m,2H),6.68-6.59(m,1H),6.51(d,J=6.9Hz,1H),3.72(br,1H),3.50-3.30(m,1H),2.87-2.81(m,1H),2.80-2.70(m,1H),2.01-1.87(m,1H),1.69-1.54(m,1H),1.24(d,J=6.2Hz,3H);13C NMR(101MHz,CDCl3)144.9,129.4,126.8,121.2,117.1,114.1,47.2,30.2,26.7,22.7.

Claims (8)

1. A preparation method of a chiral spiro diboron catalyst comprises the following steps:
in a glove box, a chiral spirocyclic diene compound and HBArF 2And adding solvent toluene into the reaction bottle, and stirring at a specified temperatureAfter 15 minutes, the temperature is restored to room temperature, and the chiral spiro diboron catalyst is prepared; adding L to react with the prepared chiral spiro diboron catalyst, stirring at room temperature for 30 minutes, removing the solvent, recrystallizing, separating and purifying to obtain an adduct of the chiral spiro diboron catalyst and L; chiral spirocyclic diene Compound, HBArF 2And L in a molar ratio of 1:2: 4; the chiral spirocyclic diene compound has the following structural formula:
Figure FDA0002692754970000011
wherein, the R group is aryl or alkyl;
the structural formula of the adduct of the chiral spiro diboron catalyst and L is as follows:
Figure FDA0002692754970000012
wherein R is aryl or alkyl, Ar isFIs fluorine-containing aryl, and L is isoquinoline or pyridine.
2. The process according to claim 1, wherein the chiral spirocyclic diene compound is prepared by:
the first step is as follows: racemic spiro [4.4] -1, 6-nonanedione and (R) -phenethylamino oxalyl hydrazine are refluxed overnight under the catalysis of iodine to obtain a pair of diastereoisomer dihydrazone compound intermediates, the (R) -dihydrazone compound with single configuration is obtained by recrystallization twice in ethanol and separation, the (R) -dihydrazone compound is hydrolyzed in an iodine-potassium iodide system to obtain an optical pure product (R) -spiro [4.4] -1, 6-nonanedione ((R) -1),
wherein the molar ratio of the racemic spiro [4.4] -1, 6-nonanedione to (R) -phenethylamino oxalyl hydrazine is 1: 1;
the second step is that: reacting the (R) -spiro [4.4] -1, 6-nonanedione ((R) -1) and 2- [ N-N-bis (trifluoromethanesulfonyl) amino ] pyridine in tetrahydrofuran at-78 ℃ for 40 minutes using potassium bis (trimethylsilyl) amide as a base to give an enol trifluoromethanesulfonate compound (2),
wherein the molar ratio of the optically pure product (R) -spiro [4.4] -1, 6-nonanedione ((R) -1), 2- [ N-N-bis (trifluoromethanesulfonyl) amino ] pyridine and bis (trimethylsilyl) amino potassium is 1:3: 3;
the third step: toluene and ethanol are mixed according to the volume ratio of 3:1 to be used as a mixed solvent, under the condition of heating reflux, the triflate enol ester compound (2) and an aryl or alkyl boric acid reagent generate Suzuki coupling reaction in the presence of tetrakis (triphenylphosphine) palladium and alkali, and the chiral spirocyclic diene compound (3) is obtained after 5 hours of reaction,
wherein the molar ratio of said alkenyl triflate compound (2) to said aryl or alkyl boronic acid reagent is 1:4, said tetrakis (triphenylphosphine) palladium is present in an amount of 10 mol%, and said aryl or alkyl boronic acid reagent has the formula RB (OH)2And R is aryl or alkyl.
3. The method of claim 2, wherein: the absolute configuration of the chiral spirodiene compound is (R) or (S).
4. The method of claim 2, wherein: the aryl is phenyl, 4-fluorophenyl, 3-phenyl or 4-phenyl.
5. Use of a chiral spirocyclic bisboron catalyst according to any one of claims 1 to 4 for catalyzing asymmetric hydrogenation of quinoline to give 2-substituted tetrahydroquinoline compounds, characterized in that: the structural formula of the quinoline is as follows:
Figure FDA0002692754970000021
wherein, R is1,R2Are all alkyl, aryl, styryl, alkynyl, conjugated dienyl or conjugated alkenylalkynyl.
6. The use according to claim 5, wherein the chiral spirocyclic diene compound of claim 1 and the HBAr of claim 1 are added sequentially to a reaction flask under nitrogen atmosphereF 2And trifluorotoluene, stirring for 15 minutes at the specified temperature, cooling to room temperature, adding 2-substituted quinoline, transferring to a high-pressure kettle, sealing, replacing with hydrogen for three times, filling to reaction pressure, reacting at-20 ℃, discharging residual hydrogen in the kettle carefully after reacting for 24 hours, heating the reaction system to room temperature, reducing pressure to remove the solvent, and performing column chromatography separation to obtain a 2-substituted tetrahydroquinoline product.
7. Use according to claim 6, characterized in that: the dosage of the trifluorotoluene is 1.0-2.0mL for each millimole of 2-substituted quinoline.
8. Use according to claim 6, characterized in that: the reaction pressure of hydrogen is 2-5 MPa.
CN201811561367.5A 2018-12-19 2018-12-19 Synthesis of spiro bisboron catalyst and application of spiro bisboron catalyst in hydrogenation reaction Active CN109575060B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201811561367.5A CN109575060B (en) 2018-12-19 2018-12-19 Synthesis of spiro bisboron catalyst and application of spiro bisboron catalyst in hydrogenation reaction

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201811561367.5A CN109575060B (en) 2018-12-19 2018-12-19 Synthesis of spiro bisboron catalyst and application of spiro bisboron catalyst in hydrogenation reaction

Publications (2)

Publication Number Publication Date
CN109575060A CN109575060A (en) 2019-04-05
CN109575060B true CN109575060B (en) 2020-11-17

Family

ID=65931117

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201811561367.5A Active CN109575060B (en) 2018-12-19 2018-12-19 Synthesis of spiro bisboron catalyst and application of spiro bisboron catalyst in hydrogenation reaction

Country Status (1)

Country Link
CN (1) CN109575060B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111171189B (en) * 2020-01-06 2022-11-08 万华化学集团股份有限公司 High-temperature-resistant catalyst system and application thereof
CN111499558B (en) * 2020-05-14 2022-10-18 南开大学 Asymmetric reduction method of chiral spiro-bis-boron catalytic substituted pyridine and application thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101012187A (en) * 2007-02-13 2007-08-08 中国科学院上海有机化学研究所 Chiral diene ligand, synthesis method and its application in asymmetric reaction
CN101148456A (en) * 2007-10-12 2008-03-26 北京大学 Organic phosphoric acid catalyst and its preparation method and application
CN101585808A (en) * 2008-05-22 2009-11-25 中国科学院化学研究所 Method for asymmetric catalytic hydrogenation of quinoline derivatives

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9108986B2 (en) * 2011-07-15 2015-08-18 Hamari Chemicals, Ltd. Method for producing optically active tetrahydroquinolines

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101012187A (en) * 2007-02-13 2007-08-08 中国科学院上海有机化学研究所 Chiral diene ligand, synthesis method and its application in asymmetric reaction
CN101148456A (en) * 2007-10-12 2008-03-26 北京大学 Organic phosphoric acid catalyst and its preparation method and application
CN101585808A (en) * 2008-05-22 2009-11-25 中国科学院化学研究所 Method for asymmetric catalytic hydrogenation of quinoline derivatives

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
C2-Symmetric Bicyclic Bisborane Catalysts: Kinetic or Thermodynamic Products of a Reversible Hydroboration of Dienes;Xian-Shuang Tu et al.;《Angew. Chem. Int. Ed.》;20190913;第15096-15100页 *
Chiral Dienes as "Ligands" for Borane-Catalyzed Metal-Free Asymmetric Hydrogenation of Imines;Yongbing Liu et al.;《Journal of the American Chemical Society》;20130422;第6810-6813页 *
喹啉及其衍生物氢化还原技术进展;王璇等;《化工时刊》;20141130;第36-39页 *

Also Published As

Publication number Publication date
CN109575060A (en) 2019-04-05

Similar Documents

Publication Publication Date Title
CN101671365A (en) Chiral spiro aminophosphine ligand compound and synthesis method as well as application thereof
JP5674059B2 (en) Catalyst for hydrogen transfer reaction containing ruthenium complex and method for producing hydrogen transfer reactant
Wang et al. Synthesis of chiral ferrocenyl aziridino alcohols and use in the catalytic asymmetric addition of diethylzinc to aldehydes
CN109575060B (en) Synthesis of spiro bisboron catalyst and application of spiro bisboron catalyst in hydrogenation reaction
CN112920221A (en) Chiral phosphoric acid with spiro-bis-dihydrobenzothiole skeleton and preparation method and application thereof
Chelucci et al. New chiral 2, 2′: 6′, 2 ″-terpyridines as ligands for asymmetric catalysis: cyclopropanation and hydrosilylation reactions
Vorontsova et al. Novel ligands based on bromosubstituted hydroxycarbonyl [2.2] paracyclophane derivatives: synthesis and application in asymmetric catalysis
CN110128439A (en) It a kind of oxa-spiro compound and its efficiently synthesizes and method for splitting
CN107445999B (en) Metal complex, preparation method and application and intermediate thereof
CN112430228B (en) Chiral 2, 3-dihydrobenzo [ b ] thiophene 1, 1-dioxide, derivative and preparation method
CN111217847B (en) Thiosilane ligand, preparation method thereof and application thereof in aryl boronization catalytic reaction
JP2018090594A (en) Rhodium catalyst and method for producing amine compound
CN114644663A (en) Chiral tridentate nitrogen phosphine ligand and application thereof in asymmetric hydrogenation reaction of ketone
CN109251227B (en) Chiral compound containing ferrocene skeleton and rigid spiro structure, synthesis and application
CN114907404A (en) 5- (2- (disubstituted phosphino) phenyl) -1-alkyl-1H-pyrazolylphosphine ligand and preparation method and application thereof
JP3957346B2 (en) Method for producing optically active alcohol
CN112812033A (en) Novel synthesis method of oseltamivir
Gamsey et al. Asymmetric hydrogenation of chiral vinyloxazaborolidines under ambient conditions
EP3409681B1 (en) N,n-bis(2-dialkylphosphinoethyl)amine-borane complex and production method therefor, and method for producing ruthenium complex containing n,n-bis(2-dialkylphosphinoethyl)amine as ligand
CN115650824B (en) Chiral diol and preparation method thereof, prepared catalyst and preparation method and application thereof
CN114890881B (en) Method for simply synthesizing allyl dicarbonyl compound
US10370393B2 (en) Stereoretentive cross-coupling of boronic acids
CN113999207B (en) Pyridyl-containing chiral NNN tridentate ligand, asymmetric catalytic hydrogenation synthesis thereof and application of pyridyl-containing chiral NNN tridentate ligand in asymmetric catalytic reaction
CN112811981B (en) Hydroxyl compound and preparation method of deuterated compound thereof
CN106699787B (en) A kind of high corresponding selection 1,1- diaryl boronation alkane derivative and preparation method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant